QOH
1 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Extracorporeal System For Carbon Dioxide Removal
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 870.4150
- Medical specialty
- Cardiovascular
- FDA definition
- An extracorporeal system for carbon dioxide removal is a system of devices and accessories that provides assisted extracorporeal carbon dioxide removal from the patient's blood in patients with acute respiratory failure, where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent. The main devices and accessories of the system include, but are not limited to, the console (hardware), software, and disposables, including, but not limited to, a gas exchanger, blood pump, cannulae, tubing, filters, and other accessories (e.g., monitors, detectors, sensors, connectors).
- Adverse events (MAUDE)
- 2023: 50
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| Hemolung Respiratory Assist System (DEN210006) | Alung Technologies, Inc. | 2021-11-13 |
Track QOH automatically
Every clearance here is in the API, with alerts when new ones post.